Molecular and Cellular Pathways Leading to Tophi Development from Uric Acid Accumulation
By
Heguo Yan
Bo Yang
Niqin Xiao
Jian Zhang
Yundong Xu
Bingbing Chen
Sanjin Zeng
He Qian
Shengyi Zhao
Rong Wang
Jing Xie
Zhaofu Li
Zhaohu Xie
June 10, 2026
Clinical Scorecard: Molecular and Cellular Pathways Leading to Tophi Development from Uric Acid Accumulation
At a Glance
Category Detail
Condition Key Mechanisms Monosodium urate (MSU) crystal deposition, inflammation, tissue fibrosis Target Population Individuals with chronic gout, particularly those with prolonged disease duration Care Setting Outpatient and inpatient settings for chronic gout management
Key Highlights
Guideline-Based Recommendations
Diagnosis
Assess serum uric acid levels and clinical presentation of gout. Management
Focus on managing hyperuricemia and associated symptoms. Monitoring & Follow-up
Regularly monitor uric acid levels and assess for tophi development. Risks
Increased risk of joint deformities, functional impairment, and renal damage. Patient & Prescribing Data
Patients with chronic gout, especially those with a disease duration exceeding ten years.
Management strategies should consider the complex pathophysiology of tophus formation.
Clinical Best Practices
Related Resources & Content
